Sign In
Buy RHHBY
$54.64
-0.630 (-1.14%)
At Close: Jul 31, 2026
Roche chairman sees greater flexibility after Novartis deal - paper
05:00am, Saturday, 06'th Nov 2021
Roche's $20.7 billion move to buy back nearly a third of its voting stock from fellow Swiss drugmaker Novartis will give it more strategic flexibility, Chairman Christoph Franz said in an interview pu
Roche says controlling family won't have to make offer to other shareholders
03:55am, Friday, 05'th Nov 2021
Roche said on Friday that its controlling family will be exempt from having to make an offer to other shareholders after the drugmaker's $20.7 billion deal to buy back Novartis's nearly one third voti
7 European Stocks to Buy to Diversify Your Portfolio
02:35pm, Thursday, 04'th Nov 2021
While exposure to U.S.-based securities continues to be a good idea, you can diversify your opportunities by considering European stocks. The post 7 European Stocks to Buy to Diversify Your Portfolio
Novartis Will Sell Back Its Roche Stake for $21 Billion. Both Stocks Are Rising.
05:32am, Thursday, 04'th Nov 2021
A Roche shareholder since 2001, Novartis expects to report a gain of $14 billion from the stake sale, which disentangles two pharma rivals.
Roche climbs on deal to buy back $21 billion stake held by Novartis
04:06am, Thursday, 04'th Nov 2021
Novartis AG and Roche Holding AG said Thursday that the Swiss pharmaceutical companies have agreed for Novartis to sell its holding of Roche bearer shares to Roche for a total consideration of $20.7 b
Novartis sells its Roche stake to Roche for $20.7 billion
02:37am, Thursday, 04'th Nov 2021
Novartis AG, a shareholder in Roche for more than 20 years, said on Thursday the two Swiss drugmakers had agreed that Roche would buy Novartis's nearly one-third voting stake in its cross-town rival f
The Hanover Insurance Group, Inc. (THG) CEO Jack Roche on Q3 2021 Results - Earnings Call Transcript
04:07pm, Thursday, 28'th Oct 2021
The Hanover Insurance Group, Inc. (THG) CEO Jack Roche on Q3 2021 Results - Earnings Call Transcript
Roche's implant for chronic eye disorder wins FDA approval
04:28pm, Friday, 22'nd Oct 2021
(Reuters) -Swiss drugmaker Roche Holding AG said on Friday the U.S. health regulator approved its eye implant for patients with a chronic disorder causing blurred vision, giving them an alternative to
Are These 2 Companies Next for Short Squeezes?
08:07am, Thursday, 21'st Oct 2021
SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.
Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)
03:50am, Thursday, 21'st Oct 2021
Roche (RHHBY) immuno-oncology drug Tecentriq gets FDA approval for yet another indication of lung cancer.
Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics
03:00pm, Wednesday, 20'th Oct 2021
Roche Holding AG (OTC: RHHBY) raised its 2021 sales forecast after posting an 8% rise in nine-month revenues, driven by demand for COVID-19 tests and the strong performance in the broader business.
Roche (RHHBY) 9M21 Sales Grow on Strong COVID-19 Tests, View Up
11:40am, Wednesday, 20'th Oct 2021
Roche (RHHBY) posts an encouraging performance in the third quarter and the first nine months of 2021 driven by demand for coronavirus tests due to the Delta variant and recovery in pharma sales.
Roche reports higher sales and lifts full-year outlook
01:24am, Wednesday, 20'th Oct 2021
By Cecilia Butini
Roche raises 2021 outlook as COVID-19 tests continue powering sales
01:20am, Wednesday, 20'th Oct 2021
Roche raised its 2021 sales forecast on Wednesday after the Swiss drugmaker posted an 8% rise in nine-month revenues, powered by demand for COVID-19 tests and strength in the overall business helped b
Roche: One Of The Best Pharma Stocks You Can Buy
10:28pm, Monday, 18'th Oct 2021
Roche: One Of The Best Pharma Stocks You Can Buy
